Weight loss drugs could help with binge eating disorder
A new systematic review suggests that GLP-1 receptor agonist drugs, typically used for weight loss, may also effectively treat binge eating disorder. The study analyzed data from over 8,000 participants across 25 trials, showing potential for reducing emotional and loss-of-control eating.
Why it matters
This finding could expand the clinical application of popular weight-loss medications to address a common and highly impairing eating disorder.
edited by Swati Mestri , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source Credit: Unsplash/CC0 Public Domain Drugs commonly used for weight loss, known as GLP-1 receptor agonists, have been found to reduce the key symptoms of binge eating disorder in a new review of evidence led by University College London (UCL) researchers.
The systematic review and meta-analysis, published in eClinicalMedicine , found that weight loss drugs can reduce binge eating episodes, loss-of-control eating and emotional eating, highlighting their potential role in treating binge eating disorder as well as obesity.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in